WALTHAM, Mass., Dec. 09, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the launch of AVIPure ® dsRNA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback